Neelesh P. Jain
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Neelesh P. Jain has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Christian Gronbeck
Department of Dermatology, University of Connecticut Health Center, Farmington, Connecticut
2 shared publications - Eric Beltrami
School of Medicine University of Connecticut Farmington, CT United States
2 shared publications - Hao Feng
Department of Dermatology, University of Connecticut Health Center, Farmington, USA
2 shared publications Hao Feng
Department of Dermatology University of Connecticut Health Center Farmington CT USA
1 shared publicationRoy G. Geronemus
Laser & Skin Surgery Center of New York New York NY USA
1 shared publication
Latest Publications
- 1 March 2024
- Published by Wiley in International Journal of Dermatology
- Vol. 63 (6) , 820-821
Elliptical Mohs layer to reduce number of Mohs stages and increase clinical efficiency
- 1 March 2024
- Published by Wiley in International Journal of Dermatology
- Vol. 63 (6) , 820-821
Elliptical Mohs layer to reduce number of Mohs stages and increase clinical efficiency
- Open Access
- 15 November 2023
- Published by JMIR Publications Inc. in JMIR Dermatology
- Vol. 6, e50381
Mohs Surgery Price Transparency and Variability at Academic Hospitals After the Implementation of the Federal Price Transparency Final Rule
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). With utilization of Mohs Micrographic Surgery (MMS) continuing to expand, understanding the cost transparency and variability of this procedure across hospitals and geographic regions is crucial. New federal legislation called The Price Transparency Final Rule went into effect in 2021, requiring hospitals to disclose the prices for at least 300 services (although not specifically for MMS). Utilizing Turquoise Health, a company that compiles nationwide hospital pricing information, we calculated the percentage of academic hospitals reporting cash and commercial insurance prices for MMS and compared median prices by payment type. For reference, we identified Medicare-reported facility and physician fees for MMS, adjusted by state. The findings indicate that fewer than half of hospitals reported both cash and commercial insurance prices for MMS and that median prices varied substantially across payor types and regions, providing initial characterization of MMS pricing and implying a need for improved pricing transparency.
- 15 November 2023
- Published by JMIR Publications Inc. in JMIR Dermatology
- Vol. 6, e50381
Open AccessMohs Surgery Price Transparency and Variability at Academic Hospitals After the Implementation of the Federal Price Transparency Final Rule
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). With utilization of Mohs Micrographic Surgery (MMS) continuing to expand, understanding the cost transparency and variability of this procedure across hospitals and geographic regions is crucial. New federal legislation called The Price Transparency Final Rule went into effect in 2021, requiring hospitals to disclose the prices for at least 300 services (although not specifically for MMS). Utilizing Turquoise Health, a company that compiles nationwide hospital pricing information, we calculated the percentage of academic hospitals reporting cash and commercial insurance prices for MMS and compared median prices by payment type. For reference, we identified Medicare-reported facility and physician fees for MMS, adjusted by state. The findings indicate that fewer than half of hospitals reported both cash and commercial insurance prices for MMS and that median prices varied substantially across payor types and regions, providing initial characterization of MMS pricing and implying a need for improved pricing transparency.
- Open Access
- 29 June 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Mohs Surgery Price Transparency and Variability at Academic Hospitals After the Implementation of the Federal Price Transparency Final Rule (Preprint)
UNSTRUCTURED This paper reports on price variability and transparency in Mohs micrographic surgery as reported by academic hospital systems since the implementation of the Hospital Price Transparency Final Rule by the US federal government.
- 29 June 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessMohs Surgery Price Transparency and Variability at Academic Hospitals After the Implementation of the Federal Price Transparency Final Rule (Preprint)
UNSTRUCTURED This paper reports on price variability and transparency in Mohs micrographic surgery as reported by academic hospital systems since the implementation of the Hospital Price Transparency Final Rule by the US federal government.